SCHEMBL16854340

SCHEMBL16854340

NC1CCN(Cc2cnc(Cl)s2)CC1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.72
LMNA P02545 3/20 0.55
GAA P10253 1/20 0.55
RECQL P46063 1/20 0.55
KMT2A Q03164 1/20 0.55
JAK2 O60674 1/20 0.45
JAK1 P23458 1/20 0.45
TYK2 P29597 1/20 0.45
JAK3 P52333 1/20 0.45
MAPT P10636 1/20 0.43
OGA O60502 2/20 0.40
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 1/20 0.37
LTA4H P09960 1/20 0.36
F10 P00742 1/20 0.36
CCR5 P51681 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18175699 0.82 ALDH1A1 (0.65) ALDH1A1LMNAGAARECQLKMT2A
SCHEMBL16854335 0.80 ALDH1A1 (0.71) ALDH1A1LMNAGAARECQLKMT2A
SCHEMBL486699 0.80 ALDH1A1 (0.66) ALDH1A1LMNAGAARECQLKMT2A
SCHEMBL4590541 0.78 ALDH1A1 (0.64) ALDH1A1LMNAGAARECQLKMT2A
SCHEMBL27814718 0.77 ALDH1A1 (0.62) ALDH1A1LMNAGAARECQLKMT2A
SCHEMBL3085138 0.77 ALDH1A1 (0.67) ALDH1A1LMNAGAARECQLKMT2A
SCHEMBL30664796 0.76 ALDH1A1 (0.57) ALDH1A1LMNAGAARECQLKMT2A
SCHEMBL12079342 0.75 ALDH1A1 (0.60) ALDH1A1LMNAGAARECQLKMT2A
SCHEMBL16854349 0.71 ACHE (0.62) ALDH1A1LMNARECQLKMT2A
SCHEMBL14132153 0.71 LMNA (1.00) ALDH1A1LMNAGAARECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3085701-B1 N, N' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF INST PHARMACOLOGY & TOXICOLOGY ACADEMY MILITARY MEDICAL SCIENCES PLA CHINA (CN) 2019-02-20 EP disclosed
US-10023565-B2 N,N′ substituted piperidinamine compounds, and preparation method and usage thereof INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2018-07-17 US disclosed
US-10023565-B2 N,N′ substituted piperidinamine compounds, and preparation method and usage thereof INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2018-07-17 US disclosed
US-10023565-B2 N,N′ substituted piperidinamine compounds, and preparation method and usage thereof INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2018-07-17 US disclosed
US-20160333002-A1 N, N' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2016-11-17 US disclosed
US-20160333002-A1 N, N' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2016-11-17 US disclosed
US-20160333002-A1 N, N' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2016-11-17 US disclosed
EP-3085701-A1 N, N' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China (CN) 2016-10-26 EP disclosed
CN-105829304-A N, n substituted piperidinamine compounds, and preparation method and usage thereof 中国人民解放军军事医学科学院毒物药物研究所 2016-08-03 CN disclosed
WO-2015090226-A1 N, N' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF 中国人民解放军军事医学科学院毒物药物研究所 2015-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023565-B2 N,N′ substituted piperidinamine compounds, and preparation method and usage thereof HSP90AB1, HSP90AB2P, HSF1 ALDH1A1 863/4885LMNA 3093/4885GAA 2102/4885
US-20160333002-A1 N, N' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF HSP90AB1, HSP90AB2P, HSF1 ALDH1A1 823/4885LMNA 3221/4885GAA 2180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.